Skip to main content
OpenTrials

Clinical trial condition

Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7

Explore clinical trials studying Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 trial results

Completed

Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer

NCT00274937

Conditions
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7, Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, +5 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 109 locations
View Trial Details
Completed

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

NCT00408694

Conditions
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7, +2 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park, California, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma

NCT00336063

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +8 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Chinese University of Hong Kong-Prince of Wales Hospital Shatin, Hong Kong
  • National Cancer Center Hospital Tokyo, Japan
  • National University Hospital Singapore Singapore
View Trial Details

Related conditions